The Report Antacids Market Size, Share &
Trends Analysis Report By Dosage Form (Tablet, Liquid), By Distribution Channel
(Retail, Hospital, Online Pharmacy), By Region (APAC, Europe, North America),
And Segment Forecasts, 2019 - 2025
The global antacid market size is expected to
reach USD 7.91 billion by 2025, according to a new report by Grand View
Research, Inc. It is projected to expand at a CAGR of 3.9% over the forecast
period. The trend of self-medication for occasional heartburn is one of the
major factors driving the market.
Growing geriatric
population is expected to positively impact the overall market for antacid.
According to the United Nations Department of Economic And Social Affairs
(DESA), the global elderly population (60 years and above), was around 962
million in 2017. This number is expected to grow at the fastest rate in Latin
America with 71% increase in population aged 60 and over, followed by Asia with
66%, Africa with 64%, North America with 41%, and Europe with 23%.
Key players operating in
antacid market focus on product enhancement to cater to patient requirements,
such as changing the dosage form into chewable tablets, powder, and jelly.
Also, these players are involved in collaborations and acquisitions to expand
their market presence. For instance, in 2017, Pfizer, Inc. entered into a
strategic agreement with AstraZeneca to acquire one of the antacid brands,
Neksium for a value of INR 75 crores in India to boost its product portfolio.
The easy availability of
antacids over-the-counter offer growth opportunities for the sales of overall
market. Some of the key players areGlaxoSmithKline plc; AstraZeneca; Pfizer,
Inc.; Sun Pharmaceuticals Industries Ltd.; Dr. Reddy’s Laboratories Ltd.; Bayer
AG; Takeda Pharmaceutical Company Limited.
Access Research Report of Antacid
Market @ www.grandviewresearch.com/industry-analysis/antacids-market
Further key findings from the report suggest:
· In 2017, tablet segment led the antacid
market due to high efficacy compared to other dosage forms. Liquid is
anticipated to be the fastest growing segment due to its palatable taste and
preferred choice for children and elderly population
· Retail pharmacy led the distribution
channel segment due its accessibility and availability. Online pharmacy is
anticipated to be the fastest growing segment due to growing adoption of Pharma
3.0 and consumer awareness
· Asia Pacific is estimated to be the largest
and fastest growing region over the forecast period due to presence of key
players such as GlaxoSmithKline plc; Pfizer Inc.; and Abbott among others
· North America held the second largest
market share in 2017 owing to increasing prevalence of different digestive
disorders
· Some of the key companies operating in this
market are GlaxoSmithKline plc; Bayer AG; Boehringer Ingelheim International
GmbH; Dr. Reddy’s Laboratories Ltd.; Reckitt Benckiser Group plc; Sun
Pharmaceuticals Ltd.; Sanofi; Takeda Pharmaceutical Company Limited; Pfizer
Inc.; and Procter & Gamble.
Grand View Research has
segmented the global antacid market based on dosage form, distribution channel,
and region:
Antacid Dosage Form Outlook (Revenue, USD Million, 2014 -
2025)
·
Tablet
·
Liquid
·
Others
Antacid Distribution Channel Outlook (Revenue, USD
Million, 2014 - 2025)
·
Hospital Pharmacy
·
Retail Pharmacy
·
Online Pharmacy
Antacid Regional Outlook (Revenue, USD Million, 2014 -
2025)
·
North America
·
Europe
·
Asia Pacific
·
Latin America
·
Middle East & Africa
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market intelligence
studies ensuring relevant and fact-based research across a range of industries,
from technology to chemicals, materials and healthcare.
No comments:
Post a Comment